Maximum issuance cap on B. Riley shares under Nasdaq rules
Company: Core Scientific
The claim, verbatim
No more than 70,289,880 shares may be issued to B. Riley Principal Capital II, equal to approximately 19.99% of shares outstanding prior to the purchase agreement, per Nasdaq rules
Source (primary)
Core Scientific 424B3 filed 2022-10-12 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “Under the applicable Nasdaq rules, in no event may we issue to B. Riley Principal Capital II under the Purchase Agreement more than 70,289,880 shares of Common Stock, which number of shares is equal to approximately 19.99% of the shares of the Common Stock outstanding immediately prior to the execution of the Purchase Agreement”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-12
Quote: “Under the applicable Nasdaq rules, in no event may we issue to B. Riley Principal Capital II under the Purchase Agreement more than 70,289,880 shares of Common Stock, which number of shares is equal to approximately 19.99% of the shares of the Common Stock outstanding immediately prior to the execution of the Purchase Agreement”